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Reactive Oxygen Species Regulate Neutrophil
Recruitment and Survival in Pneumococcal Pneumonia
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Simon S. Cross1, Paul G. Ince1, Paul G. Hellewell1, Moira K. B. Whyte1, and David H. Dockrell1
1School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, United Kingdom; 2MRC Centre for Inflammation Research, Queen’s
Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom; and 3Division of Infection and Immunity, University of Glasgow,
Glasgow, United Kingdom
Rationale: The role of NADPH oxidase activation in pneumonia is
complex because reactive oxygen species contribute to both micro-
bial killing and regulation of the acute pulmonary infiltrate. The rel-
ative importance of each role remains poorly defined in community-
acquired pneumonia.
Objectives: We evaluated the contribution of NADPH oxidase–
derived reactive oxygen species to the pathogenesis of pneumococ-
cal pneumonia, addressingboth the contribution tomicrobial killing
and regulation of the inflammatory response.
Methods: Mice deficient in the gp91phox component of the phago-
cyte NADPH oxidase were studied after pneumococcal challenge.
Measurements and Main Results: gp91phox2/– mice demonstrated no
defect in microbial clearance as compared with wild-type C57BL/6
mice. A significant increase in bacterial clearance from the lungs of
gp91phox2/– mice was associated with increased numbers of neu-
trophils in the lung, lower rates of neutrophil apoptosis, and
enhanced activation. Marked alterations in pulmonary cytokine/
chemokine expression were also noted in the lungs of gp91phox2/–
mice, characterized by elevated levels of tumor necrosis factor-a, KC,
macrophage inflammatory protein-2,monocyte chemotactic protein-
1, and IL-6. The greater numbers of neutrophils in gp91phox2/– mice
were not associated with increased lung injury. Levels of neutrophil
elastase in bronchoalveolar lavagewere not decreased in gp91phox2/–
mice.
Conclusions: During pneumococcal pneumonia, NADPH oxidase–
derived reactive oxygen species are redundant for host defense but
limit neutrophil recruitment and survival. DecreasedNADPHoxidase–
dependent reactive oxygen species production is well tolerated and
improves disease outcome during pneumococcal pneumonia by re-
moving neutrophils from the tight constraints of reactive oxygen
species–mediated regulation.
Keywords: macrophages; apoptosis; Streptococcus pneumoniae; mice;
reactive oxygen species
Individuals with chronic lung disease are susceptible to severe
forms of community-acquired pneumonia and have increased
mortality (1). The commonest cause of community-acquired
pneumonia in this population is infection with Streptococcus
pneumoniae, the pneumococcus (2). The successful resolution
of bacterial pneumonia is dependent on a coordinated immune
response with neutrophil recruitment when resident defenses
are overwhelmed (3). After clearance of bacteria, a resolution
phase, mediated by apoptosis of recruited cells and clearance by
phagocytosis, prevents tissue injury by activated neutrophils (4).
Neutrophil persistence leads to lung injury, and nonresolution
of a neutrophilic infiltrate in pneumonia can result in the acute
respiratory distress syndrome (5). Neutrophils are both effec-
tors of host defense and central arbitrators of lung injury (6).
Neutrophils kill microorganisms, using both reactive oxygen
species (ROS) and granule-associated proteases (7, 8). ROS
production in neutrophils is largely dependent on the nicotin-
amide adenine dinucleotide phosphate reduced (NADPH) oxi-
dase system (9). ROS were believed to be the major mechanism
of neutrophil-mediated antimicrobial host defense (10). An al-
ternative view proposes that ion fluxes, associated with activa-
tion of the NADPH oxidase system, activate granule-associated
proteases to mediate bacterial killing (7). Neutrophil-derived
ROS and granule-associated proteases both contribute to acute
lung injury (11, 12).
In fatal cases of pneumococcal pneumonia there are often no
viable bacteria, and a persistent neutrophilic infiltrate in the lung
is frequently the only finding (13). A dysregulated inflammatory
response and excessive production of microbicidal factors
contribute to mortality. The traditional paradigm suggests that
neutrophils producing ROS are important to bacterial clearance
but excessive neutrophil recruitment and delayed apoptosis are
harmful. Because there are many individual molecules that
contribute to both microbial killing and lung injury, under-
standing the necessary and sufficient elements for each process,
and the identification of molecules that make a disproportionate
contribution to one or other process, in specific infections, are
desirable in order to guide selective therapeutic manipulation of
the inflammatory response in pneumonia.
Mice lacking the gp91phox subunit of the NADPH oxidase
have informed our understanding of the pathogenesis of pul-
monary infections (14). Because neutrophil-derived ROS have
AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
NADPH oxidase activity is believed to be essential to mi-
crobial host defense for a wide range of pulmonary path-
ogens, although excessive production of reactive oxygen
species may contribute to lung injury.
What This Study Adds to the Field
For the commonest cause of community-acquired pneumo-
nia, pneumococcal pneumonia, NADPH oxidase activation
is not required for antimicrobial host defense, and in its
absence disease outcomes are improved.
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important roles in antimicrobial host defense, regulation of the
inflammatory response, and the induction of lung injury, we
have studied pneumococcal pneumonia in these mice. We dem-
onstrate that NADPH oxidase–dependent ROS are redundant
for pneumococcal killing and in their absence granule-associated
proteases are still released. In contrast, NADPH oxidase–
dependent ROS regulate neutrophil recruitment, activation, and
survival and have a negative impact on outcome. These results
suggest a shifting paradigm for the role of ROS in pneumococ-
cal pneumonia. Some of the results of these studies have been
previously reported in the form of an abstract (15).
METHODS
Animals
gp91phox2/– mice on a C57BL/6 background (Jackson Laboratory, Bar
Harbor, ME) were maintained as a homozygous colony. C57BL/6 mice
(Harlan, Indianapolis, IN) were used as wild-type control mice. Female
mice aged 8–12 weeks were used. All animal experiments were con-
ducted in accordance with the Home Office Animals (Scientific
Procedures) Act of 1986 with local ethics approval.
Materials
Annexin-V–phycoerythrin (PE), Ly-6G–fluorescein isothiocyanate
(FITC) (clone 1A8), CD18–PE, CD11b–PE, CD62L–PE, and isotype
controls were from BD Pharmingen (Oxford, UK). TO-PRO-3 was
from Molecular Probes (Leiden, The Netherlands).
Pneumococcal Infection Model
Pulmonary infection of mice was by direct tracheal instillation (3) with
107 colony-forming units (cfu) of type 2 pneumococci, strain D39, and
in specific experiments with type 2 pneumococci lacking pyruvate
oxidase activity (SpxB2) (16) or type 1 pneumococci (strain SSISP;
Statens Serum Institut, Copenhagen, Denmark), or mock infection with
phosphate-buffered saline (PBS). Systemic infection was by intraper-
itoneal injection with 104 cfu of D39 in 100 ml of PBS.
Collection of Bronchoalveolar Lavage, Blood, and Lungs
Mice were killed by administration of an overdose of sodium pentobar-
bitone and exsanguination. Bronchoalveolar lavage (BAL), cell differ-
entials using thin-layer cell preparations (Shandon Cytospin; Thermo
Fisher Scientific, Waltham, MA), and viable bacterial counts in lung
and blood were performed as described previously (3).
Detection of Apoptosis
Apoptosis detection was by annexin-V and TO-PRO-3 staining and
flow cytometry, as a measure of phosphatidylserine translocation and
cell viability, respectively, or by nuclear morphology on Cytospin prep-
arations, as previously described (3). Neutrophils were identified by
forward versus side scatter characteristics and Ly6G staining (3).
Neutrophil Activation
BAL neutrophil activation was determined by up-regulation of surface
CD11b and CD18 and shedding of CD62L (see the online supplement
for details).
Cytokine Production
Cytokines in BAL were measured with a mouse tumor necrosis factor
(TNF)-a ELISA Ready-SET-Go! reagent set (eBioscience, San Diego,
CA) or DuoSet ELISA development kits for mouse IL-6 and macro-
phage inflammatory protein (MIP)-2 (R&D Systems, Abingdon, UK),
in accordance with the manufacturers’ protocols. Limits of detection
were 15 pg/ml. Alternatively, cytokines were measured by BD cyto-
metric bead array (CBA) flex sets and BD FACSArray bioanalyzer
(BD Biosciences, San Jose, CA), in accordance with the manufac-
turer’s protocols. The limit of detection for KC, IL-12 p70, and IL-6
was 20 pg/ml and for MCP-1 and TNF-a it was 40 pg/ml.
Lung Injury
IgM and albumin levels in BAL were determined by ELISA (Bethyl
Laboratories, Montgomery, TX) in accordance with the manufacturer’s
protocol.
Neutrophil Elastase Activity
Neutrophil elastase activity was measured in BAL (see the online
supplement for details).
Myeloperoxidase Assay
Myeloperoxidase activity was assayed in lung homogenates (see the
online supplement for details).
Histopathology
Unlavaged lungs were fixed via the trachea with 10% buffered formalin
at 20 cm H2O and paraffin-embedded sections were prepared, sec-
tioned, stained with hematoxylin and eosin, and evaluated by pathol-
ogists (P.G.I. and S.S.C.) using a BH2 Olympus microscope (Olympus,
Tokyo, Japan).
Statistics
Statistical analysis was by t test or Mann-Whitney nonparametric
analysis as appropriate, using Prism 4.0 software (GraphPad, Inc.,
San Diego, CA). Survival was calculated by Kaplan-Meier followed by
log-rank analysis. Differences were considered significant if P , 0.05.
RESULTS
Increased Survival after High-Dose Pneumococcal Infection
in gp91phox2/– Mice
gp91phox2/– and C57BL/6 mice received a high-dose pulmonary
challenge with pneumococci, previously shown to establish
pneumonia (3), and were monitored for 10 days. Any mice that
survived for 10 days were deemed to have resolution of pneu-
monia. As shown in Figure 1, mortality was decreased in
gp91phox2/– mice compared with C57BL/6 mice. Seventeen of
25 (68.0%) C57BL/6 mice died. In contrast, 9 of 26 (34.6%)
gp91phox2/– mice died.
Increased Clearance of Bacteria from the Lungs of
gp91phox2/– Mice
To determine whether improved survival of gp91phox2/– mice
was associated with altered microbial clearance we measured
bacterial numbers in the lung and blood during pneumonia. In
keeping with their increased survival, gp91phox2/– mice had
increased pulmonary clearance of bacteria, with significantly
Figure 1. Increased survival in gp91phox2/– mice after pneumococcal
infection. Mice were instilled via the trachea with 107 cfu of type 2
pneumococci and monitored for 10 days. There was significantly
greater survival of the gp91phox2/– mice (n 5 26) compared with the
wild-type C57BL/6 control mice (n 5 25); log-rank analysis.
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fewer colony-forming units in lung homogenates and in the
blood (Figure 2). Because pneumococci can form biofilms, and
to exclude the possibility that decreased colony counts in the
lung were due to different degrees of biofilm formation between
gp91phox2/– mice and C57BL/6 mice, we performed Gram stains
on lung homogenates diluted in PBS. Although occasional clumps
of bacteria were seen there was no overall difference between
a series of samples from the two murine strains (data not
shown), suggesting the 1-log difference in colony-forming units
was not likely due to differential rates of bacterial biofilm
formation (17). In these high-dose infection models alveolar
macrophages are unable to control infection (3) and the differ-
ences observed were likely due to differences in recruited innate
immune cells. To determine whether the increased clearance of
bacteria was specific to lung infection we also measured colony
counts in the blood in a systemic infection model after intra-
peritoneal instillation of bacteria. As shown in Figure E1 (see
the online supplement), gp91phox2/– mice infected by this route
also had significantly lower bacterial colony counts.
Increased Number of Neutrophils in gp91phox2/– Mice
With evidence of early enhancement of bacterial clearance in
a model that requires recruited inflammatory cells, we next ex-
amined the contribution of quantitative differences in neutrophil
responses to high-dose pneumococcal challenge in gp91phox2/–
mice. Decreased phagocyte NADPH oxidase function is asso-
ciated with enhanced neutrophil recruitment after induction of
inflammation (14), which could account for the greater bacterial
clearance. Histopathologic sections revealed greater numbers of
neutrophils in the lungs of gp91phox2/– mice (Figures 3A–3D)
and this was confirmed by semiquantitative scoring of tissue
sections (Figures 3E and 3F) and by assessment of myeloper-
oxidase content of lung homogenates (Figure 3G). Infection
with pneumococci caused recruitment of neutrophils into the
airways of both strains of mice, with significantly greater num-
bers of neutrophils being seen in the BAL of gp91phox2/– mice
than in the BAL of C57BL/6 mice at both 24 hours (Figures 4A
and 4B) and 48 hours (Figures 4C and D) postinfection. Similar
findings were demonstrated with type 1 pneumococci, which
also produced greater numbers of neutrophils in the lungs of
gp91phox2/– mice (data not shown). Mice mock infected with
PBS had few neutrophils in the BAL, with no significant dif-
ference between C57BL/6 and gp91phox2/– mice (C57BL/6 mice,
1.3 3 103 6 0.7 3 103 [n 5 9]; gp91phox2/– mice, 1.3 3 104 6
0.4 3 104 [n 5 9]). Although there was a trend toward more
neutrophils in the gp91phox2/– mice, the numbers were small.
There was also no difference in circulating neutrophils or total
white blood cells (data not shown), as previously reported (14),
suggesting that the increased numbers of neutrophils in the
BAL were a consequence of increased recruitment or decreased
apoptosis of recruited cells or a combination of both processes.
Altered Patterns of Pulmonary Expression of
Cytokines/Chemokines Associated with Neutrophil
Recruitment during Pneumococcal Pneumonia
TNF-a is a critical early cytokine required for neutrophil re-
cruitment during pneumococcal pneumonia (18). Expression
was increased 24 and 48 hours after infection, and the level was
sustained to a much greater extent at 48 hours in the gp91phox2/–
mice (Table 1). Critical CXC chemokines associated with in-
creased TNF-a expression and neutrophil chemotaxis during
pneumococcal infection of the lung, KC (CXCL1) and MIP-2
(CXCL2) (19), were also increased (Table 1). As previously
reported, MIP-2 production peaked before KC production (18).
Because monocyte-derived chemokines such as MCP-1 (CCL2)
can amplify neutrophil recruitment in the lung, MCP-1 expres-
sion was also investigated and enhanced levels of expression
were noted, particularly at later time points after infection, in
gp91phox2/– mice relative to wild-type mice (Table 1). There was
also a significant increase in the amount of IL-6, a pleiotropic
cytokine, in BAL from the gp91phox2/– mice and the level of
expression was sustained for 48 hours (Table 1). These observed
increases were seen despite reduced numbers of bacteria in
the lungs of gp91phox2/– mice and were not observed for all
cytokines investigated; there was no difference in levels of IL-
12 (Table 1) or IL-2, IL-4, IL-5, IL-10, or IFN-g (data not
shown).
Decreased Neutrophil Apoptosis in gp91phox2/– Mice
Impaired NADPH oxidase function in activated neutrophils is
associated with reduced apoptosis induction (20). Levels of ap-
optosis were estimated in BAL 24 and 48 hours postinfection.
Cytospins from BAL showed a reduction in apoptosis in
gp91phox2/– mice compared with C57BL/6 mice (Figures 5A–
5C). Levels of neutrophil and macrophage apoptosis were also
examined by annexin-V/TO-PRO-3 staining and flow cytome-
try, with the separate cell populations determined by forward/
side scatter characteristics and Ly6G staining to identify neu-
trophils. There was a significant reduction in annexin-V–PE1/
TO-PRO-32 apoptotic neutrophils (Figures 5D and 5E), with
a similar difference when dual annexin-V–PE1/TO-PRO-31 cells
were studied (data not shown). Similarly, there were reduced
levels of apoptosis as assessed by Ly6G1/Hoechst1 neutrophils,
which persisted for at least 48 hours postinfection (see Figure
E2). Macrophage apoptosis was not significantly different be-
tween the two strains of mice postinfection (see Figure E3).
Increased Activation of PMNs from gp91phox2/– Mice
Neutrophil activation is required for NADPH oxidase assembly
and surface expression of CD11b/CD18, required for adhesion
of neutrophils to endothelial cells during inflammatory re-
sponses, is an established marker of neutrophil activation (21).
To see whether any difference in activation was apparent,
CD11b and CD18 surface expression was measured on neutro-
phils from BAL. Neutrophils from gp91phox2/– mice showed
greater activation than those from C57BL/6 mice, with higher
levels of CD11b (Figure 6A) and CD18 surface expression
(Figure 6B). In addition, there was lower surface expression of
CD62L on neutrophils from gp91phox2/– mice, as compared with
those from C57BL/6 mice after infection, in keeping with
Figure 2. Reduced bacteria in lung and blood from gp91phox2/– mice
after high-dose pneumococcal infection. Bacteria in (A) lung homoge-
nates and (B) blood from wild-type C57BL/6 control mice and
gp91phox2/– mice were determined 24 hours after intratracheal in-
stillation of 107 cfu of type 2 pneumococci. Means and SEM, Mann-
Whitney.
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a significant increase in the shedding of CD62L and enhanced
activation (Figure 6C). These findings suggested that reduced
susceptibility to apoptosis was not associated with decreased
activation.
Investigation of Lung Injury in gp91phox2/– Mice
As an increase in neutrophil numbers can be associated with
increased vascular permeability and lung injury in models of
pulmonary inflammation (6), we performed several assays to
investigate these. Despite the greater number of neutrophils in
gp91phox2/– mice, there was no significant difference in albumin
or IgM levels in BAL between the two strains (Figures 7A and
7B). Similarly, there was no difference in the ratio of wet to dry
lung weights (Figure 7C). There was no evidence of significant
lung injury in either strain after review of histology sections,
although this analysis does not exclude subtle degrees of ultra-
structural difference, which would require analysis by a tech-
nique such as electron microscopy.
Analysis of Neutrophil Elastase Production in
gp91phox2/– Mice
Because some of the consequences of NADPH oxidase activa-
tion may be mediated by the resultant activation of granule-
associated proteases rather than by ROS directly (7), we ex-
amined neutrophil elastase activity in the lungs of both murine
strains. Interestingly, as shown in Figure 8A, we observed no
decrease in neutrophil elastase activity in the lungs of gp91phox2/–
mice. There was less neutrophil elastase in gp91phox2/– mice
when values were normalized to cell numbers, but the overall
level correlated with the total number of neutrophils (see Figure
E4). Although this analysis was of BAL, rather than total lung,
it is of relevance, because analysis of neutrophil numbers in
BAL provided the same conclusion as analysis of lung homo-
genates by myeloperoxidase. This suggests that the greater
neutrophil numbers compensated for the decreased levels of
per-cell production in gp91phox2/– neutrophils. Because pneu-
mococci also produce ROS we wondered whether the generation
Figure 3. Increased numbers of neutrophils in
lung sections from gp91phox2/– mice after in-
fection with pneumococci. Shown are images
of lung sections obtained from (A and B) wild-
type C57BL/6 control mice and (C and D)
gp91phox2/– mice 48 hours after intratracheal
instillation of 107 cfu of type 2 pneumococci.
Original magnification: (A and C ) 320; (B and
D) 340. Histology shows changes of patchy
lobar consolidation with increased cellular-
ity and increased numbers of neutrophils in
the alveolar inflammatory infiltrate of the
gp91phox2/– mice. (E and F ) Semiquantitative
scoring of neutrophilic infiltration in tissue
sections (E) 24 hours (n 5 6) and (F ) 48 hours
(gp91phox2/– mice, n 5 4; C57BL/6 mice, n 5
6) after intratracheal instillation of 107 cfu of
type 2 pneumococci, showing numbers of
sections with areas of confluent alveolar neu-
trophilic infiltration in the alveoli (area, 0.5mm,
score 0; area . 0.5 mm, score 1). (G) Myelo-
peroxidase (MPO) activity in lung homoge-
nates from C57BL/6 and gp91phox2/– mice
24 hours after intratracheal instillation of 107
cfu of type 2 pneumococci; n 5 7 (each
group). DOD450 5 change in optical density
at 450 nm. Means and SEM, t test.
Figure 4. Increased numbers of neutrophils in bron-
choalveolar lavage (BAL) from gp91phox2/– mice after
infection with pneumococci. (A) Representative
appearances of cytospins of BAL from C57BL/6 mice
(top) and gp91phox2/– mice (bottom) 24 hours after
intratracheal instillation of 107 cfu of type 2 pneu-
mococci (Streptococcus pneumoniae). (B) Absolute
numbers of neutrophils (#PMN) in BAL from wild-
type C57BL/6 control mice (n 5 11) and gp91phox2/–
mice (n 5 12) from the same experiments as in (A).
(C) Absolute numbers of neutrophils in BAL 48 hours
after instillation of 107 cfu of type 2 S. pneumoniae;
n 5 5 (each group). Means and SEM, t test.
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of bacteria-produced ROS, by inducing changes in ion flux and/
or pH, could compensate for the defect in host production.
Using the SpxB2 mutant, which lacks pyruvate oxidase and
produces less than 2.3% of the H2O2 produced by the parental
strain (22), we examined whether residual generation of ROS
by pneumococci influenced neutrophil elastase release. As
TABLE 1. LEVELS OF CYTOKINES IN BRONCHOALVEOLAR LAVAGE FLUID
24 Hours 48 Hours
C57BL/6 gp91phox2/– P Value C57BL/6 gp91phox2/– P Value
TNF-a 123.0* 175.0 NS 320.0 733.5 ,0.05
(65.50–192.0)† (123.0–222.0) (307.0–582.0) (457.5–957.5)
5 ‡ 7 11 10
KC (CXCL1) 46.52 162.3 NS 40.11 89.82 ,0.05
(38.59–86.35) (38.15–234.0) (33.53–169.5) (41.46–3745)
10 9 24 18
MIP-2 (CXCL2) 187.3 424.1 , 0.05 101.8 149.2 ,0.05
(135.3–259.4) (189.0–604.5) (55.67–275.9) (101.3–1469)
10 9 24 18
MCP-1 (CCL2) 112.1 158.5 NS 92.94 284.1 ,0.001
(83.69–227.9) (88.84–421.6) (70.38–162.1) (193.4–1537)
10 9 24 18
IL-6 526.8 1079 NS 168.8 3000 ,0.05
(384.1–755.1) (252.0–1637) (142.3–182.4) (332.7–3000)
5 5 5 5
IL-12 p70 36.52 26.70 NS 33.82 43.60 NS
(32.46–43.27) (25.48–34.31) (26.09–44.00) (33.46–46.55)
10 9 24 18
Definition of abbreviations: MCP-1 5monocyte chemotactic protein-1; MIP-2 5macrophage inflammatory protein-2; NS 5 not
significant; TNF-a 5 tumor necrosis factor-a.
* Median.
† Interquartile range.
‡ Number of mice.
Figure 5. gp91phox2/– mice have reduced numbers of
apoptotic cells in the lung after infection with type 2
pneumococci. (A) Representative cytospin demonstrating
apoptotic cells (arrows) of bronchoalveolar lavage (BAL)
from C57BL/6 mice 24 hours after instillation of 107 cfu of
type 2 pneumococci D39 (Streptococcus pneumoniae). (B
and C) Percentage of apoptotic events (apoptotic cells and
bodies) in cytospins of BAL from wild-type C57BL/6
control mice (n 5 11) and gp91phox2/– mice (n 5 12)
(B) 24 hours and (C ) 48 hours after S. pneumoniae
instillation; n 5 5 (each group). (D and E ) Percentage
neutrophil (PMN) apoptosis (annexin-V–PE1/TO-PRO-32,
flow cytometry) in BAL from C57BL/6 and gp91phox2/–
mice (D) 24 hours and (E ) 48 hours after intratracheal
instillation of 107 cfu of type 2 pneumococci; n 5 5 (each
group). Means and SEM, t test.
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shown in Figure 8A the presence or absence of pyruvate oxidase
in the pneumococcus had no impact on the level of neutrophil
elastase and the presence or absence of pneumococcal oxidase
did not influence total neutrophil numbers (Figure 8B). There
was also a trend toward increased clearance of the SpxB2
mutant in the lungs of gp91phox2/– mice, although this was less
marked than we had observed with the parental strain described
above (see Table E1).
DISCUSSION
These results demonstrate that NADPH oxidase–derived ROS,
a central component of neutrophil antimicrobial defenses, are
not required for pneumococcal killing. Instead, the key role of
ROS produced by NADPH oxidase in this infection is to down-
regulate the recruitment, activation, and survival of neutrophils.
Surprisingly, although gp91phox2/– mice had increased numbers
of activated neutrophils in their lungs, the presence of these
cells did not result in increased lung injury despite preserved
levels of granule-associated proteases, and the overall effect of
deficient NADPH oxidase–dependent ROS production was en-
hanced survival. Our findings suggest that NADPH oxidase–
derived ROS are not required for antimicrobial host defense
against certain common pathogens. In addition, activated neu-
trophils do not invariably cause significant lung injury and, in
the absence of functional NADPH oxidase, may be well toler-
ated in the lung. In pneumococcal infection NADPH oxidase
activation regulates the inflammatory response but not micro-
bial killing. This is not unique to the lung and the observation of
sterile abscesses in chronic granulomatous disease (CGD) sug-
gests these principles also apply to other infections (23).
CGD, a heterogeneous condition characterized by genetic
mutations involving subunits of the phagocyte NADPH oxidase
complex, classically predisposes to infections with catalase-
positive organisms (23). These microorganisms are able to de-
grade the H2O2 produced during their own metabolism. Catalase-
negative organisms lack this ability and, in theory, the H2O2
produced by catalase-negative organisms can substitute for
defective phagocyte production of ROS. Nevertheless,
gp91phox2/– mice have been shown also to have defective
pulmonary killing of catalase-negative organisms, including
Escherichia coli, Pseudomonas aeruginosa, and Mycobacterium
tuberculosis, in vivo (24–26), and thus our finding of no defect in
pneumococcal killing in gp91phox2/– mice was unexpected. In
keeping with our findings, infection with the pneumococcus,
a catalase-negative organism, is rare in CGD (27). Neutrophils
from individuals with CGD have no defect in pneumococcal
killing in vitro (28, 29) and ROS produced by pneumococci
substitutes for host-derived ROS in pneumococcal killing by
neutrophils in vitro (28). We did not see greater numbers of
bacteria in the lung after infection with the SpxB2 mutant
pneumococcus, which suggests that, in our in vivo studies,
alternative mechanisms may include non–NADPH oxidase–
produced ROS, and antimicrobial molecules, such as proteases
and cationic peptides (7, 30, 31).
Genetically modified mice may have compensatory adapta-
tions that lead to unanticipated findings. This can be com-
pounded by the use of control mice that are not heterozygous
littermates but may occur even when control mice are litter-
mates. LFA-12/– mice, although more susceptible to infection in
a variety of models, have enhanced clearance of pneumococci
after intravenous infection because the gene knockout is asso-
ciated with greater numbers of neutrophils and greater levels of
pneumococcus-specific antibody (32). However, understanding
these compensatory changes can be informative and it is pos-
sible that other approaches, such as the use of small molecular
inhibitors, may also trigger these changes. In addition, the find-
ing of greater neutrophil numbers in response to infection is not
unique to our model of CGD, whereas the improved bacterial
clearance, to our knowledge, is unique (24, 25).
A major effect of NADPH oxidase–generated ROS in this
pneumococcal pneumonia model was to limit neutrophil re-
cruitment, activation, and survival (although the slight dif-
ference between baseline numbers of neutrophils, albeit at
low levels, means that we cannot completely exclude a small
Figure 7. No increase in lung injury in
gp91phox2/– mice after high-dose pneumococcal
infection. (A) Levels of albumin in bronchoalveo-
lar lavage (BAL) from C57BL/6 (n 5 11) and
gp91phox2/– (n 5 10) mice, 48 hours after intra-
tracheal instillation of 107 cfu of type 2 pneumo-
cocci. (B) Levels of IgM in BAL from C57BL/6 (n5
23) and gp91phox2/– (n 5 16) mice 24 hours after
intratracheal instillation of 107 cfu of type 2
pneumococci. (C ) Wet-to-dry ratio of lungs from
C57BL/6 and gp91phox2/– mice 24 hours after
intratracheal instillation of 107 cfu of type 2
pneumococci, n 5 6 (each group). Means and
SEM, Mann-Whitney.
Figure 6. Increase in neutrophil activation in
gp91phox2/– mice after infection with pneu-
mococci. Mean fluorescence intensity (MFI)
of (A) CD11b, (B) CD18, and (C ) CD62L in
bronchoalveolar lavage (BAL) from wild-type
C57BL/6 control mice and gp91phox2/– mice
24 hours after intratracheal instillation of
107 cfu of type 2 pneumococci, n 5 4 (each
group). Means and SEM, t test.
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contribution from baseline differences in neutrophil numbers in
the lung). Each of these processes could contribute to clearance,
but the current study does not allow us to determine the relative
contribution of each in the current model. ROS contribute to
cell signaling via nuclear factor-kB, activator protein (AP)-1, and
mitogen-activated protein kinases (33). gp91phox2/– mice had
increased production of proinflammatory cytokines and chemo-
kines and these will also have modified neutrophil phenotype
indirectly. The sustained production of CXC chemokines is
noteworthy because inhibition of ROS signaling by antioxidants
has previously been associated with down-regulation of CXC
chemokine expression (34), suggesting in our model a shift to
ROS-independent chemokine expression. The neutrophil acti-
vation status reflects the proinflammatory cytokine environment
and the up-regulation of b2-integrin, which, in the absence of
ROS generation (35), stimulates prosurvival pathways (36).
Delayed constitutive and Fas-mediated apoptosis occurs in
neutrophils from patients with CGD (37). Decreased levels of
apoptosis of neutrophils from patients with CGD are associated
with decreased production of antiinflammatory mediators pros-
taglandin D2 and transforming growth factor-b (38). Thus,
inhibition of apoptosis has indirect effects mediated by down-
stream cytokines/chemokines.
Activated neutrophils contribute to acute lung injury (6, 39),
but increased neutrophils in the gp91phox2/– mice did not cause
gross lung injury. However, they were associated with increased
clearance of bacteria and experiments using a model of peri-
toneal infection also confirmed enhanced clearance of bacteria
by gp91phox2/– mice, demonstrating that the increased clearance
is not unique to the pulmonary route of infection. Neutrophil
depletion (40) and inhibition of Fas-dependent neutrophil re-
cruitment (41) have improved specific microbiological outcomes
in mice with pneumococcal pneumonia, but the parameters
affected have varied and results have been dose specific. We
extend these findings by making the observation that inhibition
of NADPH oxidase negates some of the harmful effects of
neutrophils in pneumonia models. Decreasing neutrophil num-
bers protect against the negative effects of NADPH oxidase acti-
vation but potentially at the expense of limiting NADPH
oxidase–independent neutrophil killing of pneumococci in the
lungs. This may explain why gp91phox2/– mice had greater clear-
ance of bacteria in the lungs whereas neutrophil depletion pref-
erentially decreased the level of bacteremia (40). Our findings
suggest a novel approach to pneumococcal pneumonia may be
the selective manipulation of NADPH oxidase activation.
Surprisingly, gp91phox2/– mice had no evidence of decreased
neutrophil elastase because increased numbers of neutrophils
compensated for the reduction of neutrophil elastase released
per cell. Nor was the neutrophil elastase release in gp91phox2/–
mice the consequence of bacterially produced ROS. Potential
explanations for the lack of granule-associated protease–
induced acute lung injury include evidence that ROS inactivate
protease inhibitors such as a1-antiprotease (42). In keeping with
this, our preliminary data have shown evidence of increased
levels of secretory leukoprotease inhibitor, an inhibitor of
neutrophil-expressed serine proteases, in gp91phox2/– mice (see
Figure E5). Neutrophil elastase can modify the inflammatory
response by enhancing IL-8 production and inducing shedding
of surface expressed receptors (43, 44).
Previous studies using antioxidants in pneumococcal infec-
tions of the lung have shown mixed results, although increased
bacterial clearance along with increased neutrophil numbers has
been demonstrated in a mouse model after vitamin C treatment
(45). However, antioxidants do not selectively inhibit NADPH
oxidase activation. Prior models enforce the concept that ma-
nipulation of the NADPH oxidase complex does not produce
the same phenotype as antioxidant treatment after infection
(46). A future therapeutic approach would be to specifically
target the neutrophil NAPDH oxidase complex, potentially by
targeting regulatory small GTPases (47). Selective inhibition of
Rac2 would be a suitable target because it is required to activate
the NADPH oxidase complex and loss-of-function mutations in
this molecule replicate the CGD phenotype (48).
Because our findings relate specifically to pneumococcal in-
fection, rapid microbiological diagnostics would be essential to
identify patients who present with severe community-acquired
pneumonia caused by pneumococci. Only a subset of individu-
als with disease will be expected to have a poor outcome, and
thus biomarkers of the degree of ROS generation via NADPH
oxidase will be required (49). Suitable patients would then be
selected to receive adjunctive therapy, to manipulate their
NADPH oxidase activation, with the aim of improving disease
outcomes. Further studies both in model systems and in ap-
propriate populations of patients with pneumonia will be re-
quired to determine the utility of such an approach.
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Figure 8. Neutrophil elastase production in
gp91phox2/– mice. (A) Levels of neutrophil elastase
(NE) in bronchoalveolar lavage (BAL) from C57BL/
6 and gp91phox2/– mice 24 hours after instillation
of 107 cfu of type 2 pneumococci D39 or pneu-
mococci lacking pyruvate oxidase activity
(SpxB2); n 5 7 (each group). (B) Absolute num-
bers of neutrophils in BAL from the same experi-
ments as in (A). Means and SEM, Mann-Whitney.
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